Fundz Deep Dive
Everything you need to win Tevogen Bio — in one platform.
Who to reach, what to say, and why now on Tevogen Bio — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Tevogen Bio — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Contract Type
partnership
Description
Tevogen Bio shares a summary of the Company’s 2024 financing activity at the one year anniversary of being listed on the Nasdaq exchange. Additionally, on January 28, 2025, Tevogen Bio entered into an agreement to receive up to $10 million in grant funding, $2 million of which has already been received, with the potential for an additional $8 million based on the grantor’s review of the Company’s activities. This grant funding is not dilutive to existing Tevogen Bio shareholders, and may enable R&D efforts and accelerate advancements in Tevogen.AI.